Celebrating more than 85 years of innovation, Beckman Coulter Life Sciences announces its newest automated liquid handler, the Biomek NGeniuS workstation, at the virtual Advances in Genome Biology and Technology (AGBT) General Meeting.
Beckman Coulter Life Sciences debuts Biomek NGeniuS selectscience.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from selectscience.net Daily Mail and Mail on Sunday newspapers.
Beckman Coulter Life Sciences established as first us distributor of genedrive plc COVID-19 kit
As the world continues to seek solutions in response to the coronavirus pandemic, Beckman Coulter Life Sciences announces it is the first United States distributor of the Genedrive
® 96 SARS-CoV-2 kit. The agreement with the near-patient molecular diagnostics company, genedrive plc (LSE: GDR), is for distribution in the US and throughout Europe.
The Genedrive
® 96 SARS-CoV-2 kit is a simple, one-step RT-PCR test to detect SARS-CoV-2 RNA. It offers lyophilized reagents that enable product stability and allow for ambient shipping and storage. The easy to set up assay can streamline laboratory workflows, increase overall throughput, and decrease potential errors for assay set up. The Genedrive
Industry News: Beckman Coulter Life Sciences established as first US distributor of genedrive plc COVID-19 kit
The Genedrive 96 SARS-CoV-2 kit is a simple, one-step RT-PCR test to detect SARS-CoV-2 RNA
23 Feb 2021
As the world continues to seek solutions in response to the coronavirus pandemic, Beckman Coulter Life Sciences announces it is the first United States distributor of the Genedrive
® 96 SARS-CoV-2 kit. The agreement with the near-patient molecular diagnostics company, genedrive plc, is for distribution in the US and throughout Europe.
The Genedrive
® 96 SARS-CoV-2 kit is a simple, one-step RT-PCR test to detect SARS-CoV-2 RNA. It offers lyophilized reagents that enable product stability and allow for ambient shipping and storage. The easy to set up assay can streamline laboratory workflows, increase overall throughput, and decrease potential errors for assay set up. The Genedrive® 96 SARS-CoV-2 kit has received the CE-IVD mark and is currently under FDA review for
Costain said the amount it has agreed is in line with the £45million it had put aside for the payment.
The final work is expected to be finished in September, leaving it free to focus on other work such as HS2 and the construction of London s new supersewer, the Thames Tideway Tunnel.
Stock Watch - Genedrive
Diagnostics minnow Genedrive rallied after it sent the first shipments of its Covid tests to the US.
Manchester-based Genedrive has developed a PCR – polymerase chain reaction – test that delivers a quick result without needing to be sent to a lab.
It has a distribution agreement with Beckman Coulter Life Sciences, which will now focus on selling the kits in the US.